Legal Representation
Attorney
Aaron Y. Silverstein
USPTO Deadlines
Application History
49 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 10, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 9, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 30, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 30, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 30, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 30, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 30, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 10, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 10, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 10, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 10, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 10, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 23, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 22, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Feb 22, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 3, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Feb 3, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 6, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 2, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 2, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Sep 2, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 15, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 14, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 12, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 12, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 12, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 7, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 3, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 3, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 3, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 10, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 8, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 8, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 8, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 8, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 14, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 14, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 24, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 9, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 9, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 9, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 9, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 9, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 22, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 22, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 22, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 15, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 31, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 30, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars, vaccines and therapeutics
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"EARLY DEVELOPMENT"